EP0117767A1
(fr)
*
|
1983-01-07 |
1984-09-05 |
Mgi Pharma, Inc. |
Préparation des unités secondaires des vaccins de parvovirus
|
IL70704A0
(en)
*
|
1983-01-19 |
1984-04-30 |
Amgen |
Methods and materials for development of parvovirus vaccines
|
US5338674A
(en)
*
|
1983-02-25 |
1994-08-16 |
Wright Stephen E |
Process for producing a vaccine for a pathogenic RNA virus and product thereof
|
NZ209308A
(en)
*
|
1983-08-30 |
1991-08-27 |
Genentech Inc |
Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
|
US7264817B1
(en)
|
1983-08-30 |
2007-09-04 |
Genentech, Inc. |
Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
|
CA1282721C
(fr)
*
|
1984-06-04 |
1991-04-09 |
Bernard Roizman |
Virus de l'herpes simplex utilise comme vecteur
|
US5288641A
(en)
*
|
1984-06-04 |
1994-02-22 |
Arch Development Corporation |
Herpes Simplex virus as a vector
|
US4722840A
(en)
*
|
1984-09-12 |
1988-02-02 |
Chiron Corporation |
Hybrid particle immunogens
|
US5643579A
(en)
*
|
1984-11-01 |
1997-07-01 |
American Home Products Corporation |
Oral vaccines
|
AU576907B2
(en)
*
|
1984-11-01 |
1988-09-08 |
American Home Products Corporation |
Oral vaccines comprising live recombinant adenoviruses
|
US6696420B1
(en)
|
1984-11-20 |
2004-02-24 |
Institut Pasteur |
Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein
|
FR2573436B1
(fr)
*
|
1984-11-20 |
1989-02-17 |
Pasteur Institut |
Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
|
IL78775A
(en)
*
|
1985-05-15 |
1992-06-21 |
Biotech Australia Pty Ltd |
Oral vaccines
|
IL79880A0
(en)
*
|
1985-08-29 |
1986-11-30 |
Inst Medical W & E Hall |
Recombinant virus
|
US5763269A
(en)
*
|
1985-09-06 |
1998-06-09 |
Syntro Corporation |
Recombinant infectious bovine rhinotrocheitis virus
|
US5310668A
(en)
*
|
1986-06-20 |
1994-05-10 |
Merck & Co., Inc. |
Varicella-zoster virus as a live recombinant vaccine
|
DE3632038A1
(de)
*
|
1986-09-20 |
1988-03-31 |
Behringwerke Ag |
Gewebespezifische virale vektoren auf basis des lpv und ihre verwendung
|
NZ219515A
(en)
*
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
EP0349578B2
(fr)
*
|
1987-03-02 |
1998-10-28 |
Enzon Labs Inc. |
Organism ayant un "Single Chain Antibody Domain (SCAD)" á l'exterieur.
|
DE3854190T2
(de)
*
|
1987-07-27 |
1996-03-28 |
Syntro Corp |
Attenuierte herpesviren, herpesviren, die für eine aminosäuresequenz kodierende fremde dns beeinhalten und sie enthaltende impfstoffe.
|
US5182211A
(en)
*
|
1987-08-07 |
1993-01-26 |
Institut Pasteur |
Plasmid vectors encoding a protein of a picornavirus
|
FR2619012B1
(fr)
*
|
1987-08-07 |
1989-12-22 |
Pasteur Institut |
Vaccins dont l'epitope caracteristique est incorpore dans une proteine de picornavirus, notamment de poliovirus
|
US6284492B1
(en)
|
1988-02-26 |
2001-09-04 |
Large Scale Biology Corporation |
Recombinant animal viral nucleic acids
|
US20030150019A1
(en)
*
|
1988-02-26 |
2003-08-07 |
Large Scale Biology Corporation |
Monopartite RNA virus transformation vectors
|
US5316931A
(en)
*
|
1988-02-26 |
1994-05-31 |
Biosource Genetics Corp. |
Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
|
US6054566A
(en)
*
|
1988-02-26 |
2000-04-25 |
Biosource Technologies, Inc. |
Recombinant animal viral nucleic acids
|
US5037743A
(en)
*
|
1988-08-05 |
1991-08-06 |
Zymogenetics, Inc. |
BAR1 secretion signal
|
US5223409A
(en)
*
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
ATE128730T1
(de)
*
|
1988-12-13 |
1995-10-15 |
Univ Harvard |
Prototypische felv-isolate für die verwendung als krankheitsmuster oder impfstoffe.
|
US5691170A
(en)
*
|
1989-04-18 |
1997-11-25 |
Therion Biologics |
Generation of hybrid genes and proteins by virus-mediated recombination
|
US7413537B2
(en)
*
|
1989-09-01 |
2008-08-19 |
Dyax Corp. |
Directed evolution of disulfide-bonded micro-proteins
|
EP1132471A3
(fr)
|
1989-09-12 |
2001-11-28 |
F. Hoffmann-La Roche Ag |
Protéines liant le TNF
|
US5427908A
(en)
*
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
US5723286A
(en)
*
|
1990-06-20 |
1998-03-03 |
Affymax Technologies N.V. |
Peptide library and screening systems
|
US20030064480A1
(en)
*
|
1990-06-28 |
2003-04-03 |
Leander Lauffer |
Fusion proteins with immunoglobulin portions, the preparation and use thereof
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
US7063943B1
(en)
|
1990-07-10 |
2006-06-20 |
Cambridge Antibody Technology |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
WO1992006191A1
(fr)
*
|
1990-09-28 |
1992-04-16 |
Protein Engineering Corporation |
Agents d'elimination de la plaque dentaire a base de proteines
|
ATE164395T1
(de)
*
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
US5989886A
(en)
*
|
1991-01-02 |
1999-11-23 |
The Johns Hopkins University |
Method for the inhibition and prevention of viral replication using fusions of a virus protein and a destructive enzyme
|
EP0575485A1
(fr)
*
|
1991-03-01 |
1993-12-29 |
Dyax Corp. |
Procede de developpement de mini-proteines de liaison
|
GB9108386D0
(en)
|
1991-04-19 |
1991-06-05 |
Agricultural Genetics Co |
Modified plant viruses as vectors
|
WO1993000103A1
(fr)
*
|
1991-06-21 |
1993-01-07 |
The Wistar Institute Of Anatomy And Biology |
Proteines d'enveloppe chimeriques pour le ciblage de virus
|
WO1993002202A1
(fr)
*
|
1991-07-19 |
1993-02-04 |
Syngene, Inc. |
Compositions et procedes de reproduction d'indications diagnostiques positives
|
US5270170A
(en)
*
|
1991-10-16 |
1993-12-14 |
Affymax Technologies N.V. |
Peptide library and screening method
|
US5733731A
(en)
*
|
1991-10-16 |
1998-03-31 |
Affymax Technologies N.V. |
Peptide library and screening method
|
PT1696031E
(pt)
*
|
1991-12-02 |
2010-06-25 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
US6511845B1
(en)
|
1992-08-07 |
2003-01-28 |
Alan R. Davis |
Methods for producing an immune response against HIV-1
|
US5922857A
(en)
|
1992-09-28 |
1999-07-13 |
Chiron Corporation |
Methods and compositions for controlling translation of HCV proteins
|
US5633234A
(en)
*
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
AU676042B2
(en)
*
|
1993-04-14 |
1997-02-27 |
Commonwealth Scientific And Industrial Research Organisation |
Recombinant avian adenovirus vector
|
US6296852B1
(en)
|
1993-04-14 |
2001-10-02 |
Commonwealth Scientific And Industrial Research Organisation |
Recombinant avian adenovirus vector
|
EP0690912B1
(fr)
*
|
1993-04-14 |
2008-03-05 |
Commonwealth Scientific And Industrial Research Organisation |
Vecteur d'adenovirus de recombinaison avien
|
US6010861A
(en)
*
|
1994-08-03 |
2000-01-04 |
Dgi Biotechnologies, Llc |
Target specific screens and their use for discovering small organic molecular pharmacophores
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
US5559099A
(en)
*
|
1994-09-08 |
1996-09-24 |
Genvec, Inc. |
Penton base protein and methods of using same
|
US5965541A
(en)
*
|
1995-11-28 |
1999-10-12 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US6465253B1
(en)
*
|
1994-09-08 |
2002-10-15 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US5962311A
(en)
*
|
1994-09-08 |
1999-10-05 |
Genvec, Inc. |
Short-shafted adenoviral fiber and its use
|
WO1996012027A1
(fr)
|
1994-10-18 |
1996-04-25 |
Scottish Crop Research Institute |
Procede de production de proteines chimeres
|
US6127525A
(en)
*
|
1995-02-21 |
2000-10-03 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral coat protein and methods of using same
|
US5770442A
(en)
|
1995-02-21 |
1998-06-23 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral fiber protein and methods of using same
|
US6783980B2
(en)
*
|
1995-06-15 |
2004-08-31 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
JP4051416B2
(ja)
*
|
1995-06-15 |
2008-02-27 |
クルーセル ホランド ベスローテン フェンノートシャップ |
遺伝子治療に使用されるヒト組換えアデノウイルス用のパッケージングシステム
|
US6083693A
(en)
|
1996-06-14 |
2000-07-04 |
Curagen Corporation |
Identification and comparison of protein-protein interactions that occur in populations
|
AU4070499A
(en)
|
1998-04-30 |
1999-11-16 |
Cornell Research Foundation Inc. |
Adenoviral vectors with tandem fiber proteins
|
US20040043489A1
(en)
*
|
1998-07-08 |
2004-03-04 |
Menzo Havenga |
Gene delivery vectors provided with a tissue tropism for dendritic cells and methods of use
|
US20030017138A1
(en)
*
|
1998-07-08 |
2003-01-23 |
Menzo Havenga |
Chimeric adenoviruses
|
WO2000015823A1
(fr)
|
1998-09-11 |
2000-03-23 |
Genvec, Inc. |
Adenovirus a ciblage altnernatif
|
US6929946B1
(en)
*
|
1998-11-20 |
2005-08-16 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
US6492169B1
(en)
*
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
US20050232900A1
(en)
*
|
1999-05-18 |
2005-10-20 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
EP1157999A1
(fr)
*
|
2000-05-24 |
2001-11-28 |
Introgene B.V. |
Méthodes et moyens pour améliorer la transplantation de la peau en utilisant des vecteurs d'apport de genes munis d'un tropisme pour des fibroblastes primaires ainsi que d'autres utilisations de celles-ci
|
EP1301612A2
(fr)
*
|
2000-05-31 |
2003-04-16 |
Genvec, Inc. |
Methode et composition destinees au ciblage d'un vecteur adenoviral
|
NZ524743A
(en)
*
|
2000-09-20 |
2004-07-30 |
Crucell Holland B |
Gene delivery vectors provided with a tissue tropism for dendritic cells provided by a viral capsid protein
|
US7235233B2
(en)
*
|
2000-09-26 |
2007-06-26 |
Crucell Holland B.V. |
Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
|
WO2002051870A2
(fr)
*
|
2000-12-22 |
2002-07-04 |
GRAD, Carole Legal Representative of KAPLAN, Howard |
Bibliotheques d'affichage de phages de fragments vh humains
|
US20050164515A9
(en)
*
|
2001-06-05 |
2005-07-28 |
Belcher Angela M. |
Biological control of nanoparticle nucleation, shape and crystal phase
|
US20030148380A1
(en)
*
|
2001-06-05 |
2003-08-07 |
Belcher Angela M. |
Molecular recognition of materials
|
US20030113714A1
(en)
*
|
2001-09-28 |
2003-06-19 |
Belcher Angela M. |
Biological control of nanoparticles
|
US20030073104A1
(en)
*
|
2001-10-02 |
2003-04-17 |
Belcher Angela M. |
Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
|
ES2335657T3
(es)
*
|
2002-04-25 |
2010-03-31 |
Crucell Holland B.V. |
Medios y metodos para la produccion de vectores de adenovirus.
|
US20050064508A1
(en)
*
|
2003-09-22 |
2005-03-24 |
Semzyme |
Peptide mediated synthesis of metallic and magnetic materials
|
US7329486B2
(en)
*
|
2003-03-31 |
2008-02-12 |
The Board Of Regents Of The University Of Texas System |
High-throughput assay for virus entry and drug screening
|
WO2009014782A2
(fr)
*
|
2007-04-27 |
2009-01-29 |
Dow Global Technologies Inc. |
Production améliorée et assemblage in vivo de particules icosaédriques solubles recombinées analogues à un virus
|
US10736928B2
(en)
|
2016-01-20 |
2020-08-11 |
Richard Brian Murphy, JR. |
Pegylated recombinant bacteriophage
|
WO2018093932A2
(fr)
|
2016-11-16 |
2018-05-24 |
Immunomic Therapeutics, Inc. |
Acides nucléiques pour le traitement d'allergies
|
CA3061206A1
(fr)
|
2017-04-22 |
2018-10-25 |
Immunomic Therapeutics, Inc. |
Constructions ameliorees de lamp
|
KR20240027895A
(ko)
|
2017-05-02 |
2024-03-04 |
이뮤노믹 쎄라퓨틱스, 인크. |
암 항원을 포함하는 lamp (리소솜 연관 막 단백질) 구축물
|
JP2021523185A
(ja)
|
2018-05-15 |
2021-09-02 |
イミュノミック セラピューティックス, インコーポレイテッドImmunomic Therapeutics, Inc. |
アレルゲンを含む改善されたlamp構築物
|
WO2019245817A1
(fr)
|
2018-06-19 |
2019-12-26 |
Armo Biosciences, Inc. |
Compositions et méthodes d'utilisation d'agents il-10 conjointement avec une thérapie par cellules à récepteur antigénique chimérique
|
CA3153850A1
(fr)
|
2019-10-18 |
2021-04-22 |
Teri Heiland |
Constructions ameliorees de lamp comprenant des antigenes du cancer
|
IL294388A
(en)
|
2020-01-14 |
2022-08-01 |
Synthekine Inc |
il2 orthologs and methods of use
|
WO2023201201A1
(fr)
|
2022-04-10 |
2023-10-19 |
Immunomic Therapeutics, Inc. |
Constructions de lamp bicistroniques comprenant des gènes améliorant la réponse immunitaire et leurs procédés d'utilisation
|